FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2058127911> ?p ?o ?g. }

• W2058127911 endingPage "497" @default.
• W2058127911 startingPage "489" @default.
• W2058127911 abstract "Background Coupling factor 6 (CF6), a component of ATP synthase, inhibits phospholipase A2 and induces vasoconstriction. However, because arachidonic acid acts in the widespread fields of vascular biology, CF6 might exert profound effects in addition to vasoconstriction. We investigated the effect of CF6 on the gene expression profile in human umbilical vein endothelial cells. Methods and results The increased gene expression after 24-h exposure to CF6 at 10−7 mol/l, assessed by cDNA microarray (n = 3), included neuregulin-1 (1.84 ± 0.07 fold compared with control, P < 0.05) and relaxin-1 (1.74 ± 0.20, P < 0.05), both relating to congestive heart failure, urokinase type plasminogen activator receptor (1.77 ± 0.24, P = 0.06) and estrogen receptor β (1.74 ± 0.36, P = 0.08), both relating to vascular inflammation and cell infiltration, and protein arginine methyltransferase (PRMT-1; 1.73 ± 0.20, P < 0.05). Out of these genes, the enzyme relating to the synthesis (PRMT-1) of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), was further examined concomitantly with the degradation enzyme, dimethylarginine dimethylaminohydrolase 2 (DDAH-2). The ratio of PRMT-1 to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA, measured by real-time quantitative reverse transcription-polymerase chain reaction, was increased by 9 ± 2% (n = 10, P < 0.01) at 48 h after CF6 at 10−7 mol/l, whereas the ratio of DDAH-2 to GAPDH was decreased by 12 ± 2% (n = 8, P < 0.01). DDAH-2 protein and activity were decreased by 28 ± 5% (n = 5, P < 0.01) and 19 ± 2% (n = 6, P < 0.01) by CF6, respectively. ADMA release was enhanced by 20 ± 8% and NOS activity was decreased by 13 ± 1% (both n = 8, P < 0.05) by CF6. Conclusions CF6 changes the gene expression profile to be proatherogenic and functions as a novel stimulator for ADMA release by enhancing its synthesis and suppressing its degradation." @default.
• W2058127911 created "2016-06-24" @default.
• W2058127911 creator A5010283555 @default.
• W2058127911 creator A5012330250 @default.
• W2058127911 creator A5036381262 @default.
• W2058127911 creator A5049128999 @default.
• W2058127911 creator A5054686032 @default.
• W2058127911 creator A5074029622 @default.
• W2058127911 creator A5077993084 @default.
• W2058127911 creator A5078533281 @default.
• W2058127911 creator A5046842769 @default.
• W2058127911 date "2006-03-01" @default.
• W2058127911 modified "2023-09-25" @default.
• W2058127911 title "Effect of vasoconstrictor coupling factor 6 on gene expression profile in human vascular endothelial cells: enhanced release of asymmetric dimethylarginine" @default.
• W2058127911 cites W1525649419 @default.
• W2058127911 cites W1583601846 @default.
• W2058127911 cites W1970798352 @default.
• W2058127911 cites W1971061508 @default.
• W2058127911 cites W1974468195 @default.
• W2058127911 cites W1997092643 @default.
• W2058127911 cites W1998523124 @default.
• W2058127911 cites W2005836002 @default.
• W2058127911 cites W2021958247 @default.
• W2058127911 cites W2026470245 @default.
• W2058127911 cites W2041474575 @default.
• W2058127911 cites W2058385357 @default.
• W2058127911 cites W2076680300 @default.
• W2058127911 cites W2077529465 @default.
• W2058127911 cites W2079592196 @default.
• W2058127911 cites W2080105057 @default.
• W2058127911 cites W2081537828 @default.
• W2058127911 cites W2083217753 @default.
• W2058127911 cites W2083891358 @default.
• W2058127911 cites W2098154479 @default.
• W2058127911 cites W2106478344 @default.
• W2058127911 cites W2114290793 @default.
• W2058127911 cites W2125686850 @default.
• W2058127911 cites W2129254845 @default.
• W2058127911 cites W2135049825 @default.
• W2058127911 cites W2153110646 @default.
• W2058127911 cites W2153646652 @default.
• W2058127911 cites W2161887334 @default.
• W2058127911 cites W2163776379 @default.
• W2058127911 cites W2172190666 @default.
• W2058127911 cites W4293247451 @default.
• W2058127911 doi "https://doi.org/10.1097/01.hjh.0000209985.66853.1e" @default.
• W2058127911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16467652" @default.
• W2058127911 hasPublicationYear "2006" @default.
• W2058127911 type Work @default.
• W2058127911 sameAs 2058127911 @default.
• W2058127911 citedByCount "32" @default.
• W2058127911 countsByYear W20581279112012 @default.
• W2058127911 countsByYear W20581279112013 @default.
• W2058127911 countsByYear W20581279112014 @default.
• W2058127911 countsByYear W20581279112016 @default.
• W2058127911 countsByYear W20581279112017 @default.
• W2058127911 countsByYear W20581279112018 @default.
• W2058127911 countsByYear W20581279112020 @default.
• W2058127911 countsByYear W20581279112021 @default.
• W2058127911 countsByYear W20581279112022 @default.
• W2058127911 crossrefType "journal-article" @default.
• W2058127911 hasAuthorship W2058127911A5010283555 @default.
• W2058127911 hasAuthorship W2058127911A5012330250 @default.
• W2058127911 hasAuthorship W2058127911A5036381262 @default.
• W2058127911 hasAuthorship W2058127911A5046842769 @default.
• W2058127911 hasAuthorship W2058127911A5049128999 @default.
• W2058127911 hasAuthorship W2058127911A5054686032 @default.
• W2058127911 hasAuthorship W2058127911A5074029622 @default.
• W2058127911 hasAuthorship W2058127911A5077993084 @default.
• W2058127911 hasAuthorship W2058127911A5078533281 @default.
• W2058127911 hasConcept C104317684 @default.
• W2058127911 hasConcept C126322002 @default.
• W2058127911 hasConcept C134018914 @default.
• W2058127911 hasConcept C150194340 @default.
• W2058127911 hasConcept C153911025 @default.
• W2058127911 hasConcept C2777468819 @default.
• W2058127911 hasConcept C2777622882 @default.
• W2058127911 hasConcept C2779877776 @default.
• W2058127911 hasConcept C515207424 @default.
• W2058127911 hasConcept C519581460 @default.
• W2058127911 hasConcept C55493867 @default.
• W2058127911 hasConcept C71924100 @default.
• W2058127911 hasConcept C86803240 @default.
• W2058127911 hasConceptScore W2058127911C104317684 @default.
• W2058127911 hasConceptScore W2058127911C126322002 @default.
• W2058127911 hasConceptScore W2058127911C134018914 @default.
• W2058127911 hasConceptScore W2058127911C150194340 @default.
• W2058127911 hasConceptScore W2058127911C153911025 @default.
• W2058127911 hasConceptScore W2058127911C2777468819 @default.
• W2058127911 hasConceptScore W2058127911C2777622882 @default.
• W2058127911 hasConceptScore W2058127911C2779877776 @default.
• W2058127911 hasConceptScore W2058127911C515207424 @default.
• W2058127911 hasConceptScore W2058127911C519581460 @default.
• W2058127911 hasConceptScore W2058127911C55493867 @default.
• W2058127911 hasConceptScore W2058127911C71924100 @default.
• W2058127911 hasConceptScore W2058127911C86803240 @default.
• W2058127911 hasIssue "3" @default.
• W2058127911 hasLocation W20581279111 @default.

• next